Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00315120 · ClinicalTrials.gov registry record · Phase 3

Osteopathic Health Outcomes in Chronic Low Back Pain (OSTEOPATHIC) Trial

A Phase 3 study of Low Back Pain, sponsored by University of North Texas Health Science Center.

Completed
Registry status
Phase 3
Development phase
455
Enrollment target
1
Study location

NCT00315120 is a Phase 3 study of Low Back Pain that has completed, run by University of North Texas Health Science Center. The registered enrollment target is 455 participants, roughly in line with the 500-participant average among 122 other Low Back Pain trials with a reported enrollment target. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00315120, a Phase 3 study of Low Back Pain, has completed, sponsored by University of North Texas Health Science Center.

COMPLETED
Registry status
Phase 3
Development phase
455 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine whether osteopathic manipulative treatment (a type of spinal manipulative therapy used by osteopathic physicians) and ultrasound physical therapy are effective in the treatment of chronic low back pain.

Conditions Studied

Interventions

  • PROCEDURE A. Active OMT and active UST
  • PROCEDURE B. Sham OMT and active UST
  • PROCEDURE C. Active OMT and sham UST
  • PROCEDURE D. Sham OMT and sham UST

Study Locations (1)

Texas

  • The Osteopathic Research Center - Fort Worth

Trial Details

FieldValue
Enrollment Target 455 participants
Start Date 2006-08
Est. Completion 2011-01
Phase Phase 3

What the Registry Record Tells You About NCT00315120

The ClinicalTrials.gov registry entry for NCT00315120 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 455 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 500-participant average among 122 other Low Back Pain trials with a reported enrollment target. The listed sponsor is University of North Texas Health Science Center, which has 21 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Low Back Pain appearing as the primary indexed condition, and to 4 interventions - of which A. Active OMT and active UST is the first listed.

NCT00315120 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT00315120 about?

NCT00315120 is a clinical study titled "Osteopathic Health Outcomes in Chronic Low Back Pain (OSTEOPATHIC) Trial". The purpose of this study is to determine whether osteopathic manipulative treatment (a type of spinal manipulative therapy used by osteopathic physicians) and ultrasound physical therapy are effective in the treatment of chronic low back pain.

What is the current status of trial NCT00315120?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 455 participants. The study started on 2006-08. Estimated completion is 2011-01.

What conditions does trial NCT00315120 study?

This clinical trial studies the following conditions: Low Back Pain.

What interventions are being tested in trial NCT00315120?

The interventions under investigation include: A. Active OMT and active UST (PROCEDURE), B. Sham OMT and active UST (PROCEDURE), C. Active OMT and sham UST (PROCEDURE), D. Sham OMT and sham UST (PROCEDURE).

Who is sponsoring clinical trial NCT00315120?

This trial is sponsored by University of North Texas Health Science Center, which has 21 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00315120 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Low Back Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.